In addition, glucose-6-phosphate dehydrogenase (G6PD) and transketolase (TKT) exhibit exclusive roles in determining how NRF2 drives malignant progression of HNSCC. This evidence concerns the gene G6PD and head and neck squamous cell carcinoma.